Topical prostaglandin analogues and development of epiretinal membrane

Main Article Content

Juan Martín Giambruni

Downloads

##plugins.themes.bootstrap3.displayStats.noStats##

Article Details

Section

Hospital Italiano in Medline

How to Cite

1.
Giambruni JM. Topical prostaglandin analogues and development of epiretinal membrane. Rev Hosp Ital B.Aires [Internet]. 2019 Sep. 30 [cited 2026 Jul. 31];39(3):103-4. Available from: https://ojs.hospitalitaliano.org.ar/index.php/revistahi/article/view/517

References

Joshi M, Agrawal S, Christoforidis JB. Inflammatory mechanisms of idiopathic epiretinal membrane formation. Mediators Inflamm. 2013; 2013:192582.

Knyazer B, Schachter O, Plakht Y, et al. Epiretinal membrane in diabetes mellitus patients screened by nonmydriatic fondo camera. Can J Ophthalmol. 2016; 51:41-6.

Miranda AF, Costa de Andrade G, et al. Outcomes after pars plana vitrectomy for epirretinal membranes associated with toxoplasmosis. Retina. 2016; 36:1713-7.

Fraser-Bell S, Guzowski M, Rochtchina E, et al. Five-year cumulative incidence and progression of epirretinal membranes: The Blue Mountains Eye Study. Ophthalmology. 2003; 110:34-40.

Sebag J. Anomalous posterior vitreous detachment: A unifying concept in vitreo-retinal disease. Graefes Arch Clin Exp Ophthalmol. 2004; 242:690-8.

Schumer RA, Camras CB, Mandahl AK. Putative side effects of prostaglandin analogs. Surv Ophthalmol. 2002; 47(Suppl 1):S219.

Varma R, Ying-Lai M, Francis BA, et al. Los Angeles Latino Eye Study Group. Prevalence of open-angle glaucoma and ocular hypertension in Latinos: The Los Angeles Latino Eye Study. Ophthalmology. 2004; 111:1439-48.

Chu CJ, Johnston RL, Buscombe C, et al. United Kingdom Pseudophakic Macular Edema Study Group. Risk factors and incidence of macular edema after cataract surgery: A database study of 81984 eyes. Ophthalmology. 2016; 132:316-23.